The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Run-off Property-Liability; Protection Services; Allstate Health and Benefits; and Corporate and Other. The company offers private passenger auto, homeowners, personal lines, and commercial insurance products through agents, contact centers, and online; and property and casualty insurance products. It also provides consumer product protection plans, device and mobile data collection services, and analytic solutions using automotive telematics information, roadside assistance, and protection plans; and insurance products, such as identity protection and restoration through Allstate Protection Plans, Allstate Dealer Services, Allstate Roadside, Arity, and Allstate Identity Protection brands. In addition, the company offers life, accident, critical illness, hospital indemnity, short-term disability, and other health insurance products; self-funded stop-loss and fully insured group health products to employers; medicare supplement, ancillary products, and short-term medical insurance to individuals through independent agents, owned agencies, benefits brokers, and Allstate exclusive agents. Further, it offers automotive protection; vehicle service contracts, guaranteed asset protection, road hazard tires and wheels, and paintless dent repair protection; and roadside assistance, mobility data collection services, and analytic solutions using automotive telematics information, identity theft protection, and remediation services. The Allstate Corporation was founded in 1931 and is headquartered in Northbrook, Illinois.

Allstate Corporation (The)

Analysts have been eager to weigh in on the Financial sector with new ratings on Metlife (MET), Marex Group plc (MRX) and Allstate (ALL). Metlife (...

Analysts Offer Insights on Financial Companies: Metlife (MET), Marex Group plc (MRX) and Allstate (ALL)

Analysts have been eager to weigh in on the Financial sector with new ratings on Ally Financial (ALLY) and Houlihan Lokey (HLI). Ally Financial (AL...

Analysts Offer Insights on Financial Companies: Ally Financial (ALLY) and Houlihan Lokey (HLI)

An announcement from Aristocrat Leisure ( ($AU:ALL) ) is now available. Aristocrat Leisure Limited has provided an update on its on-market share bu...

Aristocrat Continues On-Market Buy-Back With Daily Share Purchases

Macquarie analyst maintained a Buy rating on Aristocrat Leisure today and set a price target of A$63.00. In addition to Macquarie, Aristocrat Leisu...

Aristocrat Leisure  (ARLUF) Receives a Buy from Macquarie

Aristocrat Leisure ( ($AU:ALL) ) has issued an announcement. Aristocrat Leisure Limited has provided a daily update on its on-market share buy-back...

Aristocrat Leisure Updates Market on Ongoing Share Buy-Back Activity

UBS analyst Andre Fromyhr maintained a Buy rating on Aristocrat Leisure today and set a price target of A$69.00. According to TipRanks, Fromyhr is ...

Aristocrat Leisure  (ARLUF) Receives a Buy from UBS

In a report released today, Liam Robertson from Jarden maintained a Buy rating on Aristocrat Leisure , with a price target of A$68.00. Robertson co...

Jarden Sticks to Their Buy Rating for Aristocrat Leisure  (ARLUF)

There’s a lot to be optimistic about in the Financial sector as 2 analysts just weighed in on Ally Financial (ALLY) and StoneX Group (SNEX) with bu...

Analysts Are Bullish on These Financial Stocks: Ally Financial (ALLY), StoneX Group (SNEX)

The latest announcement is out from Alleima AB ( ($SE:ALLEI) ). Alleima AB has published its Annual Report 2025, prepared in the European Single El...

Alleima Releases 2025 Annual Report With Enhanced EU‑Aligned Sustainability Disclosure

Aristocrat Leisure ( ($AU:ALL) ) has issued an announcement. Aristocrat Leisure has cancelled 6,074,256 ordinary fully paid shares following comple...

Aristocrat Leisure Cancels Over 6 Million Shares After On‑Market Buy‑Back

In a report released today, Andrew Kligerman from TD Cowen maintained a Hold rating on Allstate, with a price target of $231.00. Kligerman covers t...

Allstate (ALL) Receives a Hold from TD Cowen

Atlantic Lithium ( ($GB:ALL) ) has shared an announcement. Atlantic Lithium has issued 27,379,260 fully paid ordinary shares at £0.146 each under a...

Atlantic Lithium Issues New Shares Under Third Placement, Confirms Regulatory Compliance

An update from Atlantic Lithium ( ($GB:ALL) ) is now available. Atlantic Lithium Limited has applied to the Australian Securities Exchange for quot...

Atlantic Lithium Seeks ASX Quotation for 27.4 Million New Shares

In a report released on March 13, Tim Huff from Canaccord Genuity maintained a Buy rating on Atlantic Lithium. The company’s shares closed yesterda...

Canaccord Genuity Sticks to Its Buy Rating for Atlantic Lithium (ALL)

Atlantic Lithium ( ($GB:ALL) ) has shared an announcement. Atlantic Lithium Limited has notified the ASX of a proposed issue of new securities in t...

Atlantic Lithium Plans Issue of New Class B and C Warrants

An announcement from Atlantic Lithium ( ($GB:ALL) ) is now available. Atlantic Lithium Limited has notified the ASX of a proposed issue of new secu...

Atlantic Lithium Plans New Share and Warrant Issue for Capital Raising

Atlantic Lithium ( ($GB:ALL) ) has provided an announcement. Atlantic Lithium Limited has notified the ASX of a proposed placement of up to 27,379,...

Atlantic Lithium Plans Share Placement to Raise Fresh Capital

Atlantic Lithium ( ($GB:ALL) ) has issued an announcement. Atlantic Lithium has secured access to up to US$16.4m in new funding from a strategic in...

Atlantic Lithium Secures US$16.4m to Advance Ghana’s First Lithium Mine

Aristocrat Leisure ( ($AU:ALL) ) has issued an announcement. Aristocrat Leisure Limited has reported a further on-market share buy-back under its e...

Aristocrat Leisure Updates Market on Ongoing On-Market Share Buy-Back

Aristocrat Leisure ( ($AU:ALL) ) has provided an update. Aristocrat Leisure has disclosed a change in director Neil Gregory Chatfield’s holding in ...

Aristocrat Director Neil Chatfield Increases Shareholding in On‑Market Trade

Allogene Therapeutics (ALLO) has disclosed a new risk, in the Innovation / R&D category. Allogene Therapeutics faces uncertainty over whether fluda...

Current Quarter	$7.7	Next Quarter	$4.26
Current Year	$26.01	Next Year	$26.02
QoQ Growth	-44.7%	YoY Growth	+0.0%
3Y EPS CAGR	N/A	Target Price	$241.59
Consensus	Buy	Upside	+12.6%

Current Quarter Rev	N/A	Next Quarter Rev	N/A
Revenue Growth	N/A	YoY Growth	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	ALL	$214.52	+1.16%	1.06M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	ALL	$214.52	+1.2%	1.06M
3
4
5
6

ALL

ALL

EPS Estimates Overview

Quarterly EPS Estimates

Revenue Analysis

Get Allstate Corporation (The) Data in Excel

Get Allstate Corporation (The) Data in Excel